Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

Lignende værker

• A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes
  af: Li, Qiao, et al.
  Udgivet: (2015)
• Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer
  af: Dong, Si-Qi, et al.
  Udgivet: (2021)
• Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population
  af: Lin, Shaoyan, et al.
  Udgivet: (2021)
• Comparison of capecitabine-based regimens with platinum-based regimens in Chinese triple-negative breast cancer patients with liver metastasis
  af: Chen, Yimeng, et al.
  Udgivet: (2021)
• Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China
  af: Li, Yiqun, et al.
  Udgivet: (2020)